Echigo S - Search Results

1

Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors.

Kuwahara Y, Mori M, Kitahara S, Fukumoto M, Ezaki T, Mori S, Echigo S, Ohkubo Y, Fukumoto M. Kuwahara Y, et al. Among authors: echigo s. Cancer Med. 2014 Apr;3(2):310-21. doi: 10.1002/cam4.185. Epub 2014 Jan 27. Cancer Med. 2014. PMID: 24464839 Free PMC article.

2

Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.

Miyashita H, Uchida T, Mori S, Echigo S, Motegi K. Miyashita H, et al. Among authors: echigo s. Oncol Rep. 2003 Jul-Aug;10(4):1045-8. Oncol Rep. 2003. PMID: 12792768

3

Activin A increases the bone mass of grafted bone in C3H/HeJ mice.

Hirotani H, Ohtsuka-Isoya M, Mori S, Sakai R, Eto Y, Echigo S, Shinoda H. Hirotani H, et al. Among authors: echigo s. Calcif Tissue Int. 2002 Apr;70(4):330-8. doi: 10.1007/s00223-001-2037-3. Epub 2002 Apr 3. Calcif Tissue Int. 2002. PMID: 12004338

4

Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells.

Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Suzuki M, et al. Among authors: echigo s. Cancer Chemother Pharmacol. 2011 May;67(5):1129-36. doi: 10.1007/s00280-010-1417-7. Epub 2010 Aug 3. Cancer Chemother Pharmacol. 2011. PMID: 20680277

5

Differential apoptotic response of human cancer cells to organoselenium compounds.

Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Suzuki M, et al. Among authors: echigo s. Cancer Chemother Pharmacol. 2010 Aug;66(3):475-84. doi: 10.1007/s00280-009-1183-6. Epub 2009 Nov 26. Cancer Chemother Pharmacol. 2010. PMID: 19940991

6

Involvement of NF-kappaB and mitochondrial pathways in docetaxel-induced apoptosis of human oral squamous cell carcinoma.

Taniguchi T, Takahashi M, Shinohara F, Sato T, Echigo S, Rikiishi H. Taniguchi T, et al. Among authors: echigo s. Int J Mol Med. 2005 Apr;15(4):667-73. Int J Mol Med. 2005. PMID: 15754030

7

Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells.

Suzuki M, Shinohara F, Endo M, Sugazaki M, Echigo S, Rikiishi H. Suzuki M, et al. Among authors: echigo s. Cancer Chemother Pharmacol. 2009 Jul;64(2):223-32. doi: 10.1007/s00280-008-0833-4. Epub 2008 Oct 2. Cancer Chemother Pharmacol. 2009. PMID: 18830594

8

Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.

Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Suzuki M, et al. Among authors: echigo s. Cancer Chemother Pharmacol. 2009 Nov;64(6):1115-22. doi: 10.1007/s00280-009-0969-x. Epub 2009 Mar 11. Cancer Chemother Pharmacol. 2009. PMID: 19280190

9

Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.

Suzuki M, Shinohara F, Nishimura K, Echigo S, Rikiishi H. Suzuki M, et al. Among authors: echigo s. Int J Oncol. 2007 Dec;31(6):1449-56. Int J Oncol. 2007. PMID: 17982671

10

Immunohistochemical assessment of ATG7, LC3, and p62 in ameloblastomas.

Okada M, Oikawa M, Miki Y, Shimizu Y, Echigo S, Takahashi T, Kumamoto H. Okada M, et al. Among authors: echigo s. J Oral Pathol Med. 2014 Sep;43(8):606-12. doi: 10.1111/jop.12177. Epub 2014 Apr 25. J Oral Pathol Med. 2014. PMID: 24762217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters